Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Pharmaceutical Design
|
March 14, 2008
Chemical origins of isoform selectivity in histone deacetylase inhibitors
Kyle V Butler, Alan P Kozikowski
Medchemcomm
|
August 23, 2016
Non-Substrate Based, Small Molecule Inhibitors of the Human Isoprenylcysteine Carboxyl Methyltransferase
Kyle V Butler, Kelsey Bohn, Christine A Hrycyna, et al.
Journal of Chemical Information and Modeling
|
October 17, 2017
Report and Application of a Tool Compound Data Set
Kyle V Butler, Ian A MacDonald, Nathaniel A Hathaway, et al.
ACS Synthetic Biology
|
October 28, 2017
Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity
Kyle V Butler, Anna M Chiarella, Jian Jin, et al.
Scientific Reports
|
May 11, 2017
Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase
Rinku Jain, Kyle V Butler, Javier Coloma, et al.
Journal of Medicinal Chemistry
|
December 15, 2011
Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells
Jay H Kalin, Kyle V Butler, Tatiana Akimova, et al.
Medchemcomm
|
January 3, 2015
Structure-activity relationship studies of SETD8 inhibitors
Anqi Ma, Wenyu Yu, Yan Xiong, et al.
Journal of Visualized Experiments : Jove
|
October 9, 2018
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Anna M Chiarella, Tiffany A Wang, Kyle V Butler, et al.
Chemmedchem
|
June 25, 2009
Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups
Kyle V Butler, Rong He, Kathryn McLaughlin, et al.
Journal of the American Chemical Society
|
July 10, 2010
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A
Kyle V Butler, Jay Kalin, Camille Brochier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Pharmaceutical Design
|
March 14, 2008
Chemical origins of isoform selectivity in histone deacetylase inhibitors
Kyle V Butler, Alan P Kozikowski
Medchemcomm
|
August 23, 2016
Non-Substrate Based, Small Molecule Inhibitors of the Human Isoprenylcysteine Carboxyl Methyltransferase
Kyle V Butler, Kelsey Bohn, Christine A Hrycyna, et al.
Journal of Chemical Information and Modeling
|
October 17, 2017
Report and Application of a Tool Compound Data Set
Kyle V Butler, Ian A MacDonald, Nathaniel A Hathaway, et al.
ACS Synthetic Biology
|
October 28, 2017
Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity
Kyle V Butler, Anna M Chiarella, Jian Jin, et al.
Scientific Reports
|
May 11, 2017
Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase
Rinku Jain, Kyle V Butler, Javier Coloma, et al.
Journal of Medicinal Chemistry
|
December 15, 2011
Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells
Jay H Kalin, Kyle V Butler, Tatiana Akimova, et al.
Medchemcomm
|
January 3, 2015
Structure-activity relationship studies of SETD8 inhibitors
Anqi Ma, Wenyu Yu, Yan Xiong, et al.
Journal of Visualized Experiments : Jove
|
October 9, 2018
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Anna M Chiarella, Tiffany A Wang, Kyle V Butler, et al.
Chemmedchem
|
June 25, 2009
Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups
Kyle V Butler, Rong He, Kathryn McLaughlin, et al.
Journal of the American Chemical Society
|
July 10, 2010
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A
Kyle V Butler, Jay Kalin, Camille Brochier, et al.
Page
of 2